In-depth mass spectrometric mapping of the human vitreous proteome

Abstract

Mapping of proteins involved in normal eye functions is a prerequisite to identify pathological changes during eye disease processes. We therefore analysed the proteome of human vitreous by applying in-depth proteomic screening technologies. For ethical reasons human vitreous samples were obtained by vitrectomy from “surrogate normal patients” with epiretinal gliosis that is considered to constitute only negligible pathological vitreoretinal changes. We applied different protein prefractionation strategies including liquid phase isoelectric focussing, 1D SDS gel electrophoresis and a combination of both and compared the number of identified proteins obtained by the respective method. Liquid phase isoelectric focussing followed by SDS gel electrophoresis increased the number of identified proteins by a factor of five compared to the analysis of crude unseparated human vitreous. Depending on the prefractionation method proteins were subjected to trypsin digestion either in-gel or in solution and the resulting peptides were analysed on a UPLC system coupled online to an LTQ Orbitrap XL mass spectrometer. The obtained mass spectra were searched against the SwissProt database using the Mascot search engine. Bioinformatics tools were used to annotate known biological functions to the detected proteins. Following this strategy we examined the vitreous proteomes of three individuals and identified 1111 unique proteins. Besides structural, transport and binding proteins, we detected 261 proteins with known enzymatic activity, 51 proteases, 35 protease inhibitors, 35 members of complement and coagulation cascades, 15 peptide hormones, 5 growth factors, 11 cytokines, 47 receptors, 30 proteins of visual perception, 91 proteins involved in apoptosis regulation and 265 proteins with signalling activity. This highly complex mixture strikingly differs from the human plasma proteome. Thus human vitreous fluid seems to be a unique body fluid. 262 unique proteins were detected which are present in all three patient samples indicating that these might represent the constitutive protein pattern of human vitreous. The presented catalogue of human vitreous proteins will enhance our understanding of physiological processes in the eye and provides the groundwork for future studies on pathological vitreous proteome changes.

Proteomic Analysis of Macular Fluid Associated With Advanced Glaucomatous Excavation

“…Peptides derived from opticin, beta-crystallin B2, and alpha-crystallin B were detected and are unique to vitreous (not seen in CSF). 5 Because of the small volume of schisis fluid, a more targeted analysis was performed and identified approximately 80 proteins. Opticin, beta-crystallin B2, and a large number of other vitreous proteins were detected in the schisis fluid.…”

A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples

“…The human vitreous humor is an aqueous solution that fills the posterior compartment of the eye [23]. Although the substructures of the vitreous and their proteins have been investigated recently [24], studies have centered on using vitreous humor as a diagnostic tool for retinal pathologies.…”

Non-viral therapeutic approaches to ocular diseases: An overview and future directions

“…The main barrier for therapeutic compounds after intravitreal injection is the vitreous itself. Despite its clear appearance, the vitreous contains a 3D meshwork of connected fibers of collagen, hyaluronan and other proteoglycans like heparin and chondroitin sulfate which gives it its jelly-like texture (104-106). This structure caninterfere with diffusion of particles both by steric hindrance and also because charged delivery vehicles can interact with the charged proteins in the vitreous.…”